Disclosed is a compound useful in a resin composition for fabricating articles such as a prepreg, a resin film, a laminate or a printed circuit board, such that the articles have improved one or more properties including glass transition temperature, ratio of thermal expansion, peel strength, thermal resistance, dielectric constant, dissipation factor and flame retardancy.

The present invention provides an electrolyte solution for a non-aqueous electrolyte battery capable of an exerting high average discharge voltage and an excellent low-temperature output characteristic at 30 C. or lower and an excellent cycle characteristic and an excellent storage characteristic at high temperatures of 50 C. or higher, as well as a non-aqueous electrolyte battery containing the same. The present electrolyte solution comprises a non-aqueous solvent, a solute, at least one silane compound represented by the following general formula (1) as a first compound, and a fluorine-containing compound represented by the following general formula (3), for example, as a second compound. ##STR00001##

The present invention provides an electrolyte solution for a non-aqueous electrolyte battery capable of an exerting high average discharge voltage and an excellent low-temperature output characteristic at 30 C. or lower and an excellent cycle characteristic and an excellent storage characteristic at high temperatures of 50 C. or higher, as well as a non-aqueous electrolyte battery containing the same. The present electrolyte solution comprises a non-aqueous solvent, a solute, at least one silane compound represented by the following general formula (1) as a first compound, and a fluorine-containing compound represented by the following general formula (3), for example, as a second compound. ##STR00001##

Embodiments are directed to monophosphaguanidine ligands and the bis ligated metal-complexes formed therefrom, wherein the metal-ligand complexes are polymerization catalysts comprising the following structure (I).

##STR00001##

Embodiments are directed to monophosphaguanidine ligands and the bis ligated metal-complexes formed therefrom, wherein the metal-ligand complexes are polymerization catalysts comprising the following structure (I).

##STR00001##

An electrolyte solution whose residual capacity is less likely to decrease and whose percentage increase in resistance is less likely to change even after stored at high temperature. The electrolyte solution contains a compound (1) represented by the following formula (1):

R.sup.11CFX.sup.11(CH.sub.2).sub.n11COOR.sup.12

wherein R.sup.11 is H, F, a C1-C3 non-fluorinated alkyl group, or a C1-C3 fluorinated alkyl group; X.sup.11 is H or F; R.sup.12 is a C1-C3 non-fluorinated alkyl group or a C1-C3 fluorinated alkyl group; and n11 is an integer of 0 to 3; a fluorinated carbonate; and a specific additive.

An electrolyte solution whose residual capacity is less likely to decrease and whose percentage increase in resistance is less likely to change even after stored at high temperature. The electrolyte solution contains a compound (1) represented by the following formula (1):

R.sup.11CFX.sup.11(CH.sub.2).sub.n11COOR.sup.12

wherein R.sup.11 is H, F, a C1-C3 non-fluorinated alkyl group, or a C1-C3 fluorinated alkyl group; X.sup.11 is H or F; R.sup.12 is a C1-C3 non-fluorinated alkyl group or a C1-C3 fluorinated alkyl group; and n11 is an integer of 0 to 3; a fluorinated carbonate; and a specific additive.

The present invention belongs to the technical field of chemical pharmaceuticals, and relates to a compound represented by general formula (I) or formula (II) and a preparation method thereof. The compounds are biaryl derivatives with RORt activation activity. The biaryl derivatives disclosed in this invention can effectively activate the RORt protein receptor, and thereby promote the differentiation of Th17 cells and increasing the production of IL-17, which can be used as an immune modulator for the treatment of various cancers or viral infection-related diseases.

##STR00001##

The present invention belongs to the technical field of chemical pharmaceuticals, and relates to a compound represented by general formula (I) or formula (II) and a preparation method thereof. The compounds are biaryl derivatives with RORt activation activity. The biaryl derivatives disclosed in this invention can effectively activate the RORt protein receptor, and thereby promote the differentiation of Th17 cells and increasing the production of IL-17, which can be used as an immune modulator for the treatment of various cancers or viral infection-related diseases.

##STR00001##

The sulfonium salt has high photosensitivity to i-rays and high compatibility with cationically polymerizable compounds such as epoxy compounds, and is excellent storage stability in formulations containing such compounds. The sulfonium salt is represented by general formula (1). In formula (1), R represents an alkyl group or an aryl group; substituents, R1 to R5, each independently represent an alkyl group, a hydroxy group, an alkoxy group, an aryl group, an aryloxy group, a hydroxy(poly)alkyleneoxy group, or a halogen atom; R6 to R9 each independently represent an alkyl group, an aryl group, or a hydrogen atom; m.sup.1 to m.sup.5 each represent the number of occurrences of each of R1 to R5, m.sup.1 and m.sup.4 represent an integer of 0 to 3, m.sup.2 and m.sup.5 represent an integer of 0 to 4, m.sup.3 represents an integer of 0 to 5, and X.sup. represents a monovalent polyatomic anion. ##STR00001##